Mercado de tratamiento de infecciones del tracto urinario: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00005931
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 241
Buy Now

[Informe de investigación] Se espera que el mercado alcance los 11.614,32 millones de dólares en 2027 desde los 9.106,40 millones de dólares de 2019; se estima que crecerá a una tasa compuesta anual del 3,2 % entre 2020 y 2027.

El crecimiento del mercado se atribuye a la creciente prevalencia de infecciones del tracto urinario y al envejecimiento de la población. y tecnologías informáticas emergentes para el diagnóstico de orina. Sin embargo, la falta de conocimiento del producto en los países emergentes y los efectos asociados con los medicamentos obstruyen hasta cierto punto el crecimiento del mercado de Tratamiento de infecciones del tracto urinario.

Mercados regionales lucrativos para Tratamiento de infecciones del tracto urinario


Perspectivas del mercado


Creciente incidencia de infecciones del tracto urinario

Las mujeres tienen un mayor riesgo de desarrollar infecciones del tracto urinario (ITU) que los hombres. Las infecciones urinarias, si no se tratan, pueden provocar un dolor intenso junto con graves consecuencias para los riñones. Las infecciones urinarias muestran ciertos síntomas, como necesidad persistente de orinar, inflamación, cambios en la apariencia de la orina y náuseas. La creciente prevalencia de infecciones urinarias es uno de los factores destacados que impulsan el crecimiento del mercado de tratamiento de infecciones del tracto urinario. Por ejemplo, según un estudio realizado por un grupo de investigadores del Colegio Estadounidense de Médicos y la Sociedad de Enfermedades Infecciosas de América en 2020, las infecciones urinarias representan aproximadamente 6 millones de visitas al médico cada año en los EE. UU.

Ciertos factores de riesgo, como la actividad sexual, la mala higiene y el envejecimiento, pueden provocar infecciones urinarias. También se estima que la creciente incidencia de estos factores de riesgo impulsará el crecimiento del mercado de tratamiento de infecciones del tracto urinario para 2027. Según un estudio publicado en el International Journal of Environmental Research and Public Health en 2019, los pacientes con enfermedades crónicas existentes, como la enfermedad de las arterias coronarias ( La EAC), la enfermedad renal crónica (ERC) y la diabetes mellitus (DM) tienen altas posibilidades de adquirir ITU. Por lo tanto, la alta epidemiología de las ITU genera demanda de sus productos de tratamiento, lo que eventualmente impulsa el crecimiento del mercado.

Información basada en clases de medicamentos

Basado en clase de fármaco, el segmento de quinolonas tuvo la mayor cuota de mercado en 2019; sin embargo, se prevé que el segmento de penicilina y combinación registre la tasa compuesta anual más alta del mercado del 4,5% durante el período previsto. El crecimiento futuro del mercado de las quinolonas se atribuye principalmente al hecho de que las recetan más comúnmente los médicos. La ciprofloxacina, la levofloxacina y la enoxacina se encuentran entre los fármacos más utilizados para el tratamiento.

Mercado de tratamiento de infecciones del tracto urinario, por clase de medicamento: 2019 y 2027


Perspectivas basadas en indicaciones

El mercado del tratamiento de infecciones del tracto urinario, por indicación, es segmentadas en infecciones complicadas del tracto urinario e infecciones no complicadas del tracto urinario. El segmento de infecciones complicadas del tracto urinario tuvo una mayor participación de mercado en 2019; Además, se prevé que el segmento registre una CAGR más alta en el mercado durante el período de pronóstico.

Información basada en el canal de distribución

El tracto urinario El mercado de tratamiento de infecciones, por canal de distribución, se segmenta en farmacias hospitalarias, clínicas de ginecología y urología, farmacias minoristas y farmacias en línea. El segmento del canal de distribución de farmacias hospitalarias tuvo la mayor participación del mercado en 2019, mientras que se prevé que el segmento de farmacias en línea registre la CAGR más alta del mercado durante el período de pronóstico.

< h3>Perspectivas estratégicas

Los actores del mercado del tratamiento de infecciones del tracto urinario, como Shionogi & Co., Ltd.; Teva Industrias Farmacéuticas Ltd;  Allergan; y Pfizer, han estado adoptando varias estrategias orgánicas e inorgánicas para mejorar sus ingresos y su posición en el mercado. Por ejemplo, en abril de 2019, Teva Pharmaceutical Industries Ltd anunció el lanzamiento de una versión genérica de las tabletas VESIcare (succinato de solifenacina), de 5 mg y 10 mg, en EE. UU.

< h3>Mercado de tratamiento de infecciones del tracto urinario– por clase de fármaco
  • Penicilina y combinaciones
  • Quinolonas
  • Cefalosporina
  • Antibióticos aminoglucósidos
  • Sulfonamidas< /li>
  • Suplementos nutricionales


Mercado del tratamiento de infecciones del tracto urinario: por indicación

  • Infección complicada del tracto urinario
  • Infección no complicada del tracto urinario


Mercado de tratamiento de infección del tracto urinario: por canal de distribución

  • Farmacias hospitalarias
  • Clínicas de ginecología y urología
  • Farmacias minoristas y droguerías
  • Farmacias online


Mercado de tratamiento de infecciones del tracto urinario – ndash; por Geografía

  • América del Norte
    • Estados Unidos
    • Canadá
    • México
  • < li>Europa
    • Francia
    • Alemania
    • Italia
    • Reino Unido
    • España
    • Resto de Europa
  • Asia Pacífico (APAC)
    • China
    • India
    • Corea del Sur
    • Japón
    • Australia
    • Resto de Asia Pacífico
  • Medio Oriente y África (MEA)
    • Sudáfrica
    • Arabia Saudita
    • EAU
    • Resto de Oriente Medio y África
  • Sur y Centroamérica
    • Brasil
    • Argentina
    • Resto de Sudamérica y Centroamérica

Perfiles de la empresa

  • Teva Pharmaceutical Industries Ltd
  • Sun Pharmaceutical Industries Ltd
  • Mylan NV
  • < li>ALLERGAN
  • Pfizer Inc.
  • Cipla Ltd
  • F. Hoffmann-La Roche Ltd
  • Shionogi Inc.
  • Amway
  • DuPont Nutrition & Biociencias
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The List of Companies - Urinary Tract Infection Treatment Market

 

  1. Teva Pharmaceutical Industries Ltd
  2. Sun Pharmaceutical Industries Ltd
  3. Mylan N.V.
  4. ALLERGAN
  5. Pfizer Inc.
  6. Cipla Ltd
  7. F. Hoffmann-La Roche Ltd
  8. Shionogi Inc.
  9. Amway
  10. DuPont Nutrition & Biosciences

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports